[1]李石.肝纤维化发生机制[J].中华消化杂志, 1999, 19 (1) ∶48-50.
|
[2]Bauer M, Schuppan D.TGF beta1 in liver fibrosis:time to changeparadigms?[J].FEBS Lett, 2001, 502 (1-2) ∶1-3.
|
[3] 中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) ∶324-329.
|
[4]Bissell DM, Roulot D, George J, et al.Transforming growth factorβand liver[J].Hepatology, 2001, 34 (5) ∶859-867.
|
[5]Nagashio Y, Ueno H, Imamura M, et al.Inhibition of transforminggrowth factor beta decreases pancreatic fibrosis and protects the pan-creas against chronic injury in mice[J].Lab Invest, 2004, 84 (12) ∶1610-1618.
|
[6]卢平, 周力, 张永宏.转化生长因子β1-Smads信号传导与肝纤维化的关系[J].临床肝胆病杂志, 2006, 22 (1) ∶69-71.
|
[7]李兵顺, 阎文昭, 刘金星, 等.纤维化肝组织转化生长因子β1表达与肝纤维化程度的关系[J].中华传染病杂志, 2005, 23 (2) ∶112-114.
|
[8]张愚, 屈文东, 黄华, 等.bFGF及TGF-β1在实验性肝硬化中的免疫组化研究[J].胃肠病学和肝病学杂志, 2005, 14 (1) ∶40-44.
|
[1] | Yan CHAI, Tao ZHANG, Yinke FAN, Aiwu HUI, Lintao ZHAO, Fang LI, Xiaoli ZHANG. Effect of Yangxue Rougan pills on the TGF-β1/Smad signaling pathway in a rat model of liver fibrosis induced by multiple factors[J]. Journal of Clinical Hepatology, 2022, 38(9): 2040-2045. doi: 10.3969/j.issn.1001-5256.2022.09.018 |
[2] | YUSUFUKADIER·Maimaitinijiati, AIMAITI·Yasen, Li WenDing, Ran Bo, TUERGANAILI.aji, Shao YingMei, Wen Hao. Effect of the transforming growth factor-β1 signaling pathway in inducing the differentiation of hepatic progenitor cells[J]. Journal of Clinical Hepatology, 2020, 36(3): 620-623. doi: 10.3969/j.issn.1001-5256.2020.03.030 |
[3] | An BaiQuan, Xin YongNing, Lu LinLin, Xuan ShiYing. Effect of PNPLA3 I148M mutation on expression of TGF- β1 in rat hepatic stellate cells[J]. Journal of Clinical Hepatology, 2016, 32(4): 769-771. doi: 10.3969/j.issn.1001-5256.2016.04.035 |
[4] | Gao HuiXia, Liu YuZhen, Lu JianHua, Ye LiHong, Dai ErHei. Correlation of Foxp3 + Tregs and TGFβ1 expression with inflammation in livers of patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(12): 952-955. |
[5] | Kang HaiYan, Dong JiangLong, Wang JianBin, Liu Lian, Ye LiHong, Chen YongLiang, Zheng YanHua. Expression of basic fibroblast growth factor in liver cancer and chronic hepatitis B [J]. Journal of Clinical Hepatology, 2010, 26(1): 80-81. |
[6] | Tang YanPing, Wan Hong, Zhou Jian. Characterization of hepathic pathophysiology and immunohistochemistry in patients with HBeAg positive and HBeAg negative chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(6): 407-409. |
[7] | Kang HaiYan, Dong JiangLong, Ye LiHong, Wang JianBin, Liu Lian, Yin ShuYing. Relationship between the expression of BFGF/TGF-β1 in liver tissue and liver fibrosis/inflammation in 260 patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2009, 25(2): 97-99. |
[9] | Xu TingTing, Jiang MiaoNa, Jia YuJie, Che Ying. Ganfukang's effect on transforming growth factor β1 and laminin of experimental liver fibrosis rats[J]. Journal of Clinical Hepatology, 2005, 21(1): 30-31. |
[10] | Liao Dan, Jiang JianNing, Luo GuangHan, Wu JiZhou. The expression and significance of TGF-β1 and smad4m RNA in chronic viral hepatitis and cirrhosis[J]. Journal of Clinical Hepatology, 2005, 21(2): 89-91. |
[11] | Ling YunFeng, Feng ZhenBo, He RuKun, Lu: ZiLi. Expression of TGFβ1、TGFβRⅠ and TGFβRⅡ in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2005, 21(1): 35-37. |
[13] | Bi Qing, Cheng Lei, Cui LiAn, Zhang JunFu. The effect of Kangxianruanjian on TGF β1 and it's the recepters in liver fibrosis in rats[J]. Journal of Clinical Hepatology, 2002, 18(3): 181-182. |
[14] | Li QingHua, Li Hui, Qin ChengYong, Han GuoQing. The significance of urine transforming growth factor-β1 (TGF-β1) and serum procollagen type Ⅲ (PCⅢ) , collagen type Ⅳ (Ⅳ-C) , hyaluronic (HA) and laminin (LN) in patient with chronic HBV related liver disease[J]. Journal of Clinical Hepatology, 2001, 17(3): 161-162. |
[15] | Zhang Min, Zhang LingXia, Xin ShaoJie, Zhao JingMin, Wang SongShan, Wang LinJie. The relationship between transforming growth factor β1 and liver fibrosis[J]. Journal of Clinical Hepatology, 2000, 16(1): 32-33. |